Brief: Cytek Biosciences Q3 Revenue USD 52.293 Million Vs. IBES Estimate USD 51.5 Million
05/11/2025 21:05
Nov 05 (Reuters) - Cytek Biosciences Q3 net income USD -5.478 million. Q3 adjusted gross margin 53% Q3 adjusted EBITDA USD 2.45 million Q3 pretax profit USD -7.769 million outlook FY revenue USD 196-205 million
Recent news on Cytek Biosciences
See all newsCytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says (updated)
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says
Cytek Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cytek Biosciences Q2 revenue slightly misses estimates
Brief: Cytek Biosciences Q2 Revenue USD 48.14 Million